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Abstract. 
 
In this report, we have analyzed the potential 
role and mechanisms of integrin signaling through FAK 
in cell cycle regulation by using tetracycline-regulated 
expression of exogenous FAK and mutants. We have 
found that overexpression of wild-type FAK acceler-
ated G1 to S phase transition. Conversely, overexpres-
 
sion of a dominant-negative FAK mutant 
 
D
 
C14 inhib-
ited cell cycle progression at G1 phase and this 
inhibition required the Y397 in 
 
D
 
C14. Biochemical 
analyses indicated that FAK mutant 
 
D
 
C14 was mislo-
calized and functioned as a dominant-negative mutant 
by competing with endogenous FAK in focal contacts 
for binding signaling molecules such as Src and Fyn, re-
sulting in a decreases of Erk activation in cell adhesion. 
Consistent with this, we also observed inhibition of 
BrdU incorporation and Erk activation by FAK Y397F 
mutant and FRNK, but not FRNK
 
D
 
C14, in transient 
transfection assays using primary human foreskin fibro-
blasts. Finally, we also found that 
 
D
 
C14 blocked cyclin 
D1 upregulation and induced p21 expression, while 
wild-type FAK increased cyclin D1 expression and de-
creased p21 expression. Taken together, these results 
have identified FAK and its associated signaling path-
ways as a mediator of the cell cycle regulation by inte-
grins.
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F
 
ocal
 
 adhesion kinase (FAK)
 
1
 
 is a cytoplasmic pro-
tein tyrosine kinase that has been implicated to
play an important role in integrin-mediated signal
transduction pathways (Clark and Brugge, 1995; Schwartz
et al., 1995; Parsons, 1996). FAK becomes activated and
tyrosine phosphorylated in integrin-mediated cell adhe-
sion and is colocalized with integrins and other cytoskele-
tal proteins in focal contacts in a variety of adherent cells
(Schwartz et al., 1995). Although the mechanism of FAK
activation by integrins is not fully understood at present,
physical interactions of FAK with the integrin cytoplasmic
domain as well as cytoskeletal proteins talin, paxillin, and/
or tensin have been proposed to play a key role in FAK
activation by facilitating its oligomerization and transphos-
phorylation (Giancotti, 1997; Guan, 1997).
Upon activation and autophosphorylation at Y397, FAK
associates with another tyrosine kinase Src by binding to
its SH2 (Src homology 2) domain (Chan et al., 1994; Cobb
et al., 1994; Schaller et al., 1994; Xing et al., 1994). Phos-
phorylation of Y925 of FAK by Src then recruits the Grb2
adaptor protein, which has been proposed to trigger down-
stream signaling pathways leading to activation of extracel-
lular signalÐregulated kinase (Erk) (Schlaepfer et al., 1994;
Schlaepfer and Hunter, 1996). The FAK/Src complex has
been shown to phosphorylate additional substrates includ-
ing paxillin and p130cas, which have also been proposed to
mediate downstream functions of FAK (Turner and Miller,
1994; Schaller and Parsons, 1995; Vuori et al., 1996;
Schlaepfer et al., 1997). In addition, the phosphorylated
Y397 has been mapped as the major binding site for the
SH2 domains of the regulatory subunit (p85) of phospha-
tidylinositol 3-kinase (PI 3-kinase) and FAK association
with PI 3-kinase in cell adhesion could trigger activation of
PI 3-kinase and its signaling pathways (Chen et al., 1996).
Together, FAK interactions with these and potentially
other proteins are believed to mediate FAKÕs functions in
integrin-dependent signal transduction.
Recent studies have suggested that integrin signaling
through FAK plays an important role in regulation of cell
spreading and migration. Inhibition of FAK by overex-
pression of its non-catalytic COOH-terminal domain re-
sulted in decreased rate of cell spreading and cell migra-
tion (Richardson and Parsons, 1996; Gilmore and Romer,
1996). Furthermore, cultured fibroblasts isolated from FAK
null mice, which demonstrated an embryonic lethal pheno-
type, showed markedly reduced cell motility in vitro (Ilic
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Abbreviations used in this paper:
 
 BrdU, 5-bromodeoxyuridine; CDK,
cyclin-dependent kinase; CS, calf serum; E4Y1, poly(Glu,Tyr); Erk, extra-
cellular signalÐregulated kinase; FAK, focal adhesion kinase; FN, fi-
bronectin; MBP, myelin basic protein; PI 3-kinase, phosphatidylinositol
3-kinase; SH2, Src homology 2; WT, wild type.
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et al., 1995). Finally, we have shown that stable overex-
pression of FAK in CHO cells resulted in increased migra-
tion (Cary et al., 1996). Using this system, we are begin-
ning to dissect the role of FAK interactions with various
other signaling molecules and downstream pathways in
cell migration (Cary et al., 1996, 1998).
Several recent reports also raised the possibility that
FAK may regulate cell proliferation and survival. Expres-
sion of a membrane-anchored FAK that is constitutively
active in suspended cells prevented cell detachmentÐinduced
apoptosis of MDCK cells (Frisch et al., 1996). Conversely,
inhibition of FAK by microinjection of either the COOH-
terminal fragment or an mAb caused cell cycle arrest and
apoptosis (Gilmore and Romer, 1996; Hungerford et al.,
1996). However, the biochemical mechanisms on the down-
stream pathways upon FAK inhibition were not investi-
gated in these studies because of the limitation of the
microinjection method. Furthermore, other studies have
shown that FAK gene knockout did not affect prolifera-
tion of FAK
 
2
 
/
 
2
 
 fibroblasts (Ilic et al., 1995) and that
some integrins control cell cycle progression by coupling
to Shc but not FAK (Wary et al., 1996, 1998).
To investigate potential roles of FAK in cell cycle regu-
lation and their molecular mechanisms, we have obtained
high level and inducible expressions of exogenous FAK
and its mutant in NIH3T3 cells using the tetracycline-regu-
lated expression system. Using this inducible expression
system as well as other approaches, we show that FAK
serves as a mediator of cell cycle regulation by integrins
and provide evidence suggesting that FAK/Src complex
formation in the focal contacts, Erk activation, and cyclin
D1 and/or p21 are some of the important FAK down-
stream events in the signaling pathway leading to cell cycle
regulation.
 
Materials and Methods
 
Antibodies
 
The mouse mAb 12CA5 (
 
a
 
-HA), the rabbit polyclonal 
 
a
 
-PY antibodies
and the rabbit polyclonal 
 
a
 
-FAK serum have been described previously
(Chen and Guan, 1994; Chen et al., 1995). Rabbit 
 
a
 
-p21, 
 
a
 
-p27, and 
 
a
 
-cyclin
D1 are gifts from Dr. Y. Xiong (University of North Carolina, Chapel
Hill, NC). Rabbit 
 
a
 
-integrin 
 
a
 
5 is a gift from Dr. R. Hynes (Massachussets
Institute of Technology, Cambridge, MA). The following antibodies were
purchased as indicated: 
 
a
 
-BrdU mouse mAb from Sigma (St. Louis, MO);
 
a
 
-phosphotyrosine mouse mAb PY20 from Transduction Laboratories
(Lexington, KY); rabbit 
 
a
 
-Src, 
 
a
 
-Fyn, 
 
a
 
-Erk, 
 
a
 
-cyclin A, 
 
a
 
-cyclin E,
 
a
 
-Cdk2, 
 
a
 
-His (His-Probe), and mouse mAb 
 
a
 
-Shc from Santa Cruz Bio-
technology, Inc. (Santa Cruz, CA); rabbit 
 
a
 
-Shc from UBI (Lake Placid,
NY); and rabbit 
 
a
 
-phospho-MAPK from New England Biolabs, Inc.
(Beverly, MA).
 
Transient Transfection with FAK and Mutants
 
Expression vectors encoding epitope-tagged WT FAK (pKH3-FAK) and
Y397F mutant (pKH3-Y397F) were as described previously (Chen et al.,
1996). The plasmid encoding 
 
D
 
C14 mutant (pKH3-
 
D
 
C14) was generated
by insertion of an XbaI linker containing stop codons into the ClaI site
near the 3
 
9
 
 of FAK coding sequence. The FRNK sequence of FAK was
PCR amplified from pGEX2T-FAK.KC (Chen and Guan, 1994) using the
following forward and reverse primers: 5
 
9
 
-GAATGAGAATGGGATC-
CAGGCGACAAG-3
 
9
 
 and 5
 
9
 
-CCGGGAGCTGCATGTGTCAGAGG-
3
 
9
 
. The PCR reaction was carried out using Deep Vent DNA polymerase,
digested with BamHI and EcoRI, and cloned into pKH3 to generate
pKH3-FRNK. The plasmid encoding FRNK with 
 
D
 
C14 mutant (pKH3-
FRNK
 
D
 
C14) was generated by replacing the NdeIÐEcoRI fragment in
 
pKH3-FRNK with the corresponding fragment from FAK
 
D
 
C14 in the
pTet-Splice vector (see below). Human foreskin fibroblasts (HFF) cells
were maintained in DMEM supplemented with 10% FCS (Life Technolo-
gies, Inc., Gaithersburg, MD). NIH3T3 cells were maintained in DME
supplemented with 10% calf serum (CS; Life Technologies, Inc.). The
cells were transfected with expression plasmids (pKH3-FAK, pKH3-
Y397F, pKH3-
 
D
 
C14, pKH3-FRNK, or pKH3-FRNK
 
D
 
C14) or pKH3
(control) using LipofectAMINE (Life Technologies, Inc.), as described
previously (Chen et al., 1996). One day after transfection, cells were pro-
cessed for analysis of BrdU incorporation as described below.
 
Generation of Cell Lines with Inducible
FAK Expression
 
The 5
 
9
 
 end segment of FAK cDNA with the triple hemagglutinin (HA)
epitope tag and the 3
 
9
 
 end segment of FAK cDNA were excised as a SalIÐ
NdeI fragment from pKH3-FAK (Chen et al., 1996) and a NdeIÐEcoRV
fragment from pBS-FAK (Cary et al., 1998), respectively. They were then
ligated into the cloning site of pTet-Splice (Life Technologies, Inc.). HA
epitopeÐtagged FAK cDNAs lacking the last 14 residues were excised as
SalIÐClaI fragments from pKH3-FAK and pKH3-Y397F (Chen et al.,
1996), respectively, and inserted into pTet-Splice.
The plasmids encoding FAK, 
 
D
 
C14, and 
 
D
 
C14F were transfected into
NIH3T3 cells along with the plasmids pTet-tTAk (Life Technologies,
Inc.) and pSV2neo as described previously (Chen et al., 1996) using Lipo-
fectAMINE (Life Technologies, Inc.). The cells were then selected in 0.5
mg/ml G418 in the medium with 0.4 
 
m
 
g/ml tetracycline. Several clones
were isolated after 2Ð3 weeks, which exhibited inducible expression of the
transfected FAK upon removal of tetracycline. They are designated as
WT FAK, 
 
D
 
C14, and 
 
D
 
C14F cells, respectively. The mock cells were gen-
erated similarly with pTet-Splice vector without insert. All cell lines were
maintained in DME with 10% CS, 0.5 mg/ml G418 and 0.4 
 
m
 
g/ml tetracy-
cline to suppress exogenous FAK expression until experiments as indi-
cated.
 
Analysis of 5-Bromodeoxyuridine Incorporation
 
Subconfluent cells were serum starved for 48 h in DME with 0.5% CS, 0.5
mg/ml G418, and 0.4 
 
m
 
g/ml tetracycline. They were then washed twice
with DME and incubated for 16 h or as indicated with 100 
 
m
 
M 5-bromode-
oxyuridine (BrdU) (Sigma) in DME plus 10% CS, 0.5 mg/ml G418, and
with (uninduced) or without (induced) 0.4 
 
m
 
g/ml tetracycline. Transiently
transfected HFF cells and NIH3T3 cells were serum starved and incu-
bated with BrdU similarly but without G418 or tetracycline. Cells were
then processed for immunofluorescent staining with 
 
a
 
-BrdU mAb, 
 
a
 
-FAK,
and Hoechst (Sigma), as described below. The percentage of BrdU (
 
1
 
)
cells was determined for 
 
z
 
500 cells in multiple fields in each independent
experiment. For transiently transfected cells, 
 
z
 
40Ð50 positively trans-
fected cells in multiple fields were scored for BrdU staining in each inde-
pendent experiment. Statistical analyses were performed by Minitab Re-
lease 10.5 Xtra (Minitab Inc., State College, PA).
 
FACS
 
¨
 
 Analysis
 
Serum-starved cells (0 h) were washed twice with DME and incubated for
16 h in DME plus 10% CS, 0.5 mg/ml G418, and with (uninduced) or with-
out (induced) 0.4 
 
m
 
g/ml tetracycline. They were then trypsinized and
washed twice with DME plus 10% CS. The cells were lysed and the nuclei
were stained by incubation in a hypotonic propidium iodide solution (0.05
mg/ml propidium iodide, 0.1% Triton X-100, and 0.1% sodium citrate) on
ice for 30 min. 10
 
4
 
 nuclei from each sample were applied to Becton Dick-
inson FACSCalibur
 
¨
 
 (Lincoln Park, NJ) for determination of DNA con-
tent using CELLQuestª software (version 1.2), as described previously
(Nicoletti et al., 1991). Statistical analyses were performed by Minitab Re-
lease 10.5 Xtra (Minitab Inc.).
 
Immunoprecipitations and Western Blots
 
For most experiments, cells were washed twice with ice-cold PBS and then
lysed with NP-40 lysis buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 1% NP-
40, 10% glycerol, 1 mM NaVO
 
4
 
, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin, and 20
 
m
 
g/ml leupeptin) as described previously (Chen et al., 1996). For the Erk
activation and Shc phosphorylation experiments, cell lysates were pre-
pared in ice-cold modified radioimmunoprecipitation assay (RIPA) buffer
(50 mM Hepes, pH 7.4, 150 mM NaCl, 10% glycerol, 1.5 mM MgCl
 
2
 
, 1 mM 
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EGTA, 1 mM sodium vanadate, 10 mM sodium pyrophosphate, 10 mM
NaF, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl-
sulfate, 10 
 
m
 
g/ml leupepetin, 10 
 
m
 
g/ml aprotinin, and 1 mM PMSF). As a
positive control for Shc activation, cells were stimulated with recombinant
PDGF-BB (25 ng/ml; UBI) before lysis.
Lysates were cleared by centrifugation and total protein concentrations
were determined using Bio-Rad Protein Assay (Hercules, CA). Immuno-
precipitations were carried out at 4
 
8
 
C by incubating cell lysates for 2 h
with 
 
a
 
-HA, 
 
a
 
-Src, 
 
a
 
-Fyn, 
 
a
 
-Shc, 
 
a
 
-His, or 
 
a
 
-phospho-MAPK as indicated,
followed by incubation for 1 h with protein GÐPlus (Sigma) or protein
AÐSepharose (Sigma). After washing, the beads were then resuspended in
SDS-PAGE sample buffer, boiled for 5 min, and resolved by SDS-PAGE.
The Western blots were performed with 
 
a
 
-HA (1:1,000), 
 
a
 
-FAK (1:5,000),
 
a
 
-Erk (1:1,000), 
 
a
 
-p21 (1:1,000), 
 
a
 
-p27 (1:2,000), 
 
a
 
-cyclin D1 (1:5,000),
 
a
 
-Cdk2 (1:5,000), 
 
a
 
-cyclin A (1:2,000), 
 
a
 
-cyclin E (1:2,000), 
 
a
 
-His (1:1,000),
 
a
 
-Shc (1:1,000), 
 
a
 
-PY (1:2,000), or PY20 (1:2,000) using the enhanced
chemiluminescence (ECL) system (Amersham Life Science, Inc., Arling-
ton Heights, IL), as described previously (Xing et al., 1994). In some ex-
periments, equal amounts of protein lysates were analyzed directly by
Western blotting.
 
Immunofluorescence Staining
 
Cells were processed for immunofluorescence staining as described (Guan
et al., 1991). The primary antibodies used were 
 
a
 
-HA (1:50), 
 
a
 
-integrin 
 
a
 
5
(1:200), 
 
a
 
-BrdU (1:300), and 
 
a
 
-FAK (1:300). The secondary antibodies
used were FITC-conjugated antiÐmouse or antiÐrabbit antibodies (1:300;
Sigma) and rhodamine-conjugated antiÐmouse or antiÐrabbit antibodies
(1:200; Sigma). In 
 
a
 
-BrdU staining experiments, cellular DNA was di-
gested with DNase I (0.5 units/ml; New England Biolabs, Inc., Beverly,
MA) for 20 min at 37
 
8
 
C before staining with the primary antibodies and
nuclei were stained with Hoechst (0.5 
 
m
 
g/ml) for 10 min at room tempera-
ture before mounting for analyses by immunofluorescent microscopy.
 
In Vitro Kinase Assays
 
For FAK kinase assays, cell lysates were immunoprecipitated by 
 
a
 
-HA as
described above. The immune complexes were washed and subjected to in
vitro kinase assays with or without exogenous substrates poly(Glu,Tyr)
(E4Y1), as described previously (Cary et al., 1996). For Src and Fyn ki-
nase assays, cell lysates were immunoprecipitated by 
 
a
 
-Src or 
 
a
 
-Fyn as de-
scribed above. The immune complexes were washed and subjected to in
vitro kinase assays with acid-denatured enolase as substrates, as described
previously (Schlaepfer et al., 1997). For mitogen-activated protein kinase
(MAPK) (Erk1/2) assays, cell lysates were immunoprecipitated by 
 
a
 
-His
(for transiently transfected His-tagged Erk2, a kind gift of Dr. M. Rober-
son, Cornell University, Ithaca, NY) or 
 
a
 
-phospho-MAPK (for endoge-
nous Erks1/2) as described above. The immune complexes were washed
three times with ice-cold modified RIPA buffer and twice with kinase
buffer (50 mM Tris, pH 7.4, and 10 mM MgCl
 
2
 
). They were then incubated
in 48 
 
m
 
l kinase buffer containing 5 
 
m
 
g myelin basic protein (MBP), 25 
 
m
 
M
ATP and 10 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP for 30 min at 30
 
8
 
C. The kinase reactions
were stopped by addition of SDS sample buffer, boiled for 5 min, and then
resolved on a 15% SDS-PAGE. The gel was dried and subjected to auto-
radiography. The phosphorylated MBP bands were excised from the gel
and the 
 
32
 
P incorporation was determined by Cerenkov counting.
 
Results
 
Analysis of Cell Cycle Regulation by FAK in HFF and 
NIH3T3 Cells Using Transient Transfection
 
To investigate the potential role of FAK in the cell cycle
regulation, we transiently transfected primary HFF cells or
NIH3T3 cells with expression vectors encoding wild-type
(WT) FAK or its mutants and then analyzed the effects on
cell cycle progression by measuring BrdU incorporation,
as described in Materials and Methods. As shown in Fig. 1
 
A
 
, overexpression of WT FAK resulted in an increase in
new DNA synthesis in comparison with the control HFF
cells. In contrast, both Y397F mutant (with Y397 con-
verted to F) and 
 
D
 
C14 mutant (lacking the COOH-termi-
 
nal 14 amino acids of FAK) inhibited BrdU incorporation
under the same conditions. Fig. 1 
 
B
 
 shows that overexpres-
sion of WT FAK or Y397F did not result in any alterations
of new DNA synthesis under the experimental conditions
in NIH3T3 cells (
 
P
 
 5 
 
0.42 and 0.24 compared with values
from control cells, respectively). However, 
 
D
 
C14 caused a
significant reduction of BrdU incorporation in these cells.
Taken together these results suggested that FAK may play
a role in cell cycle regulation although its effects on pri-
mary HFF cells are more pronounced than in NIH3T3
cells whose cell cycle control may have become less depen-
dent on FAK through the countless number of passages.
They also suggested that 
 
D
 
C14 functioned as a stronger in-
hibitor of cell cycle progression than Y397F and that it
could work in both primary HFF cells and NIH3T3 cells
under the experimental conditions.
 
Analysis of Inhibition of Cell Cycle Progression by 
 
D
 
C14 Using an Inducible Expression System
 
To investigate the mechanisms by which 
 
DC14 inhibited
Figure 1. Inhibition of new DNA synthesis by Y397F and DC14.
(A) HFF cells were transiently transfected with expression vec-
tors encoding WT FAK, DC14, or Y397F, as indicated. The con-
trol cells (C) were transfected by pKH3 vector alone. They were
then analyzed for BrdU incorporation as described in Materials
and Methods. The percentage of BrdU (1)/positively transfected
cells was determined by analyzing 40Ð50 positively transfected
cells for each transfection in multiple fields. The results show
mean 1 SE for at least three independent experiments. *P 5
0.0041 and 0.036 in comparison to value from control cells for
DC14 and Y397F, respectively. **P 5 0.014 in comparison to
value from control cells. (B) Similar experiments were performed
with transiently transfected NIH3T3 cells. The results show mean 1
SE for at least three independent experiments. *P 5 0.046 in
comparison to value from control cells.The Journal of Cell Biology, Volume 143, 1998 2000
cell cycle progression, we generated inducible overexpres-
sion of WT FAK, DC14 and another mutant DC14F in
NIH3T3 cells using the tetracycline-regulated expression
system (Freundlieb et al., 1997). DC14F is a double mutant
lacking the COOH-terminal 14 amino acids of FAK and
with Y397 converted to F. Fig. 2 shows the regulated ex-
pression of DC14 by removal of tetracycline in the media.
Lysates were prepared from cells at various times after re-
moval of tetracycline and subjected to Western blot analy-
sis by a-FAK or mAb a-HA that recognizes the triple HA
epitope tags fused to the NH2 terminus of FAK and mu-
tants. Expression of DC14 was detected by a-HA 4Ð8 h af-
ter tetracycline removal and it reached a maximal level 12 h
after induction (Fig. 2 b). Western blotting with a-FAK con-
firmed expression of DC14 and densitometric analysis in-
dicated an approximate eightfold level of expression of
DC14 in comparison with the endogenous FAK in unin-
duced cells (Fig. 2 d). No expression of DC14 was detected
in uninduced cells by either a-HA (Fig. 2 a) or a-FAK
(Fig. 2 c).
The effect of induced expression of DC14 on cell cycle
progression was examined by measuring BrdU incorpora-
tion in response to serum stimulation of quiescent cells. As
shown in Fig. 3 A, the majority of the uninduced cells en-
tered S phase as detected by a-BrdU staining at 16 hr after
serum stimulation (Fig. 2, a and b). In contrast, induction
of DC14 expression led to a significant inhibition of new
DNA synthesis (Fig. 2, c and d). Similar inhibition of
BrdU incorporation was also observed when DC14 expres-
sion was induced in asynchronous cells (data not shown).
Quantitative analysis of two different clones in three inde-
pendent experiments showed that induction of DC14 ex-
pression decreased new DNA synthesis by z40Ð50% com-
pared with uninduced cells (Fig. 3 B). At 24 and 36 h after
serum stimulation, more cells with induced expression of
DC14 entered S phase. However, z20% cells did not show
new DNA synthesis even at 36 h after serum stimulation.
Under both uninduced and induced conditions, z90% of
Mock cells entered S phase at 16 h after serum stimulation
and nearly 100% had incorporated BrdU at 24 and 36 h af-
ter serum stimulation.
The inhibitory effect of DC14 on DNA synthesis was
further examined by varying its expression levels using dif-
ferent concentrations of tetracycline. Fig. 3 C shows the
decrease in inhibition of BrdU incorporation as the con-
centration of tetracycline was increased. As expected, de-
creasing expression levels of DC14 were observed under
these conditions (Fig. 3 C, inset). DC14 inhibited new
DNA synthesis by z50% at the maximal expression level
Figure 2. Induction of DC14 expression by removal of tetracy-
cline. DC14 cells were incubated in media in the presence (unin-
duced, U) or absence (induced, I) of 0.4 mg/ml tetracycline. At
the indicated times, lysates were prepared and analyzed by West-
ern blot with a-HA or a-FAK.
Figure 3. Inhibition of new DNA synthesis by DC14. (A) Quies-
cent DC14 cells were stimulated with 10% CS in the presence
(uninduced, U) or absence (induced, I) of 0.4 mg/ml tetracycline.
16 hr after stimulation, the cells were processed for immunofluo-
rescent staining with a-BrdU and Hoechst dye staining, as de-
scribed in Materials and Methods. (B) Similar experiments were
performed for Mock cells and two clones of DC14 cells, as de-
scribed in A. The percentage of BrdU (1) cells at 16, 24, and 36 h
after stimulation was determined by analyzing z500 cells in mul-
tiple fields. (C) The percentage of BrdU (1) Mock (n) and DC14
(s) cells at 16 h after serum stimulation in media containing indi-
cated concentrations of tetracycline. The inset shows the induced
expression of DC14 at various tetracycline concentrations, as de-
tected by a-HA Western blot.Zhao et al. Cell Cycle Regulation by FAK 2001
(16 ng/ml tetracycline), while the inhibition was only
z20% at the low expression level (125 ng/ml tetracycline).
Tetracycline at these concentrations had no effect on new
DNA synthesis of Mock cells. Taken together, these data
suggested that overexpression of the FAK mutant DC14
inhibited cell cycle progression, which are consistent with
data obtained from HFF cells and NIH3T3 cells by tran-
sient transfection assays.
DC14 Inihibits Cell Cycle Progression by Interfering 
with Endogenous FAK
To determine whether DC14 inhibited cell cycle progres-
sion by interfering with endogenous FAK function or by
other mechanisms, we analyzed the effects on cell cycle by
overexpression of WT FAK and DC14F mutant. Fig. 4 A
shows expression of the exogenous FAK and mutants
upon induction by removal of tetracycline in the media, as
detected by a-HA (Fig. 4 A, lanes I, top). Western blotting
with a-FAK confirmed overexpression of the exogenous
FAK and mutants at similar levels (Fig. 4 A, bottom). No
expression of the exogenous FAK or the mutants was de-
tected in the presence of tetracycline (Fig. 4 A, lanes U).
The effects of induced expression of FAK and the mu-
tants on cell cycle progression were then examined by
measuring BrdU incorporation 16 h after serum stimula-
tion of quiescent cells (Fig. 4 B). As expected, expression
of DC14 led to efficient inhibition of new DNA synthesis
(Fig. 4 B, aÐc). In contrast, expression of DC14F or WT
FAK did not block BrdU incorporation under the same
conditions (Fig. 4 C, dÐi). Quantitative analysis of multiple
experiments showed that induction of DC14 expression
decreased new DNA synthesis by z40Ð50% compared
with uninduced cells or Mock cells under either induced or
uninduced conditions (Fig. 4 C). Similar analysis indicated
that DC14F had no effect on BrdU incorporation. Interest-
ingly, such quantitative analysis revealed that overexpres-
sion of WT FAK resulted in a small, but statistically signif-
icant (P 5 0.013) increase in new DNA synthesis under
these conditions. Analysis of BrdU incorporation at 12 h
after serum stimulation confirmed a positive effect of WT
FAK on cell cycle progression (Fig. 5). Approximately
15% of cells with induced WT FAK expression entered S
phase in comparison with only 3Ð4% of the uninduced
cells or the Mock cells under either induced or uninduced
conditions.
As an independent measure to evaluate the role of FAK
in cell cycle progression, we analyzed the DNA content af-
ter induction of exogenous FAK expression by FACS¨.
Fig. 6 A shows that in response to serum stimulation, simi-
lar fractions of Mock cells exited the G1 phase as mea-
sured by DNA content under the induced and uninduced
conditions (Fig. 6 A, aÐc). However, induction of DC14 ex-
pression significantly decreased the fraction of cells exiting
G1 phase in comparison to cells under uninduced condi-
tions (Fig. 6 A, dÐf). Conversely, expression of WT FAK
accelerated G1 exit (Fig. 6 A,  jÐl) while induction of
DC14F expression did not affect cells to exit G1 (Fig. 6 A,
Figure 4. Effects on cell cycle progression by overexpression of
FAK and mutants. (A) a-HA or a-FAK Western blot of whole
cell lysates prepared from cells expressing the indicated proteins
under uninduced (lanes U) and induced (lanes I) conditions. (B)
a-FAK immunofluorescence (a, d, g), a-BrdU immunofluores-
cence (b, e, h) and Hoechst dye staining (c, f, i) of cells expressing
DC14 (aÐc), DC14F (dÐf), and WT (gÐi). (C) The percentage of
BrdU (1) cells expressing the indicated proteins at 16 h after se-
rum stimulation under uninduced (open bars) and induced
(closed bars) conditions. The results show mean 1 SE for at least
three independent experiments. *P 5 0.0022 in comparison to
value from uninduced cells.
Figure 5. WT FAK stimulation of cell cycle progression. The per-
centage of BrdU (1) Mock or WT FAK cells at 12 h after serum
stimulation under uninduced (open bars) and induced (closed
bars) conditions. The results show mean 1 SE for three indepen-
dent experiments. *P 5 0.0059 in comparison to value from unin-
duced cells.The Journal of Cell Biology, Volume 143, 1998 2002
gÐi). Fig. 6 B shows quantitative analysis of results from
three such experiments, which are consistent with that ob-
tained from the BrdU incorporation assays. Because in-
creased expression of FAK promoted cell cycle progres-
sion, these results strongly suggested that FAK mutant
DC14 inhibited the cell cycle at G1 phase by interfering
with the endogenous FAK function rather than by other
mechanisms. They also suggested that Y397 was necessary
for the dominant negative effect of DC14.
Competition of Mislocalized DC14 with
Endogenous FAK
Focal contacts localization and associations with a variety
of intracellular signaling molecules are critical for FAK
functions (Hildebrand et al., 1993; Parsons, 1996; Guan,
1997). The COOH-terminal 14 residues of FAK have been
shown to be necessary for focal contacts localization of a
GST fusion protein containing the COOH-terminal third
of FAK (Tachibana et al., 1995). It is therefore possible
that DC14 is not localized in focal contacts and behaves as
a dominant-negative mutant by competing with the endog-
enous FAK in focal contacts in binding with other cellular
signaling molecules. To test this possibility, we first com-
pared subcellular localization of DC14 with that of WT
FAK in the induced NIH3T3 cells (Fig. 7). Immunofluo-
rescent staining with a-HA showed a diffuse cytoplasmic
distribution of DC14 (Fig. 7 a) and a typical focal contacts
localization of WT FAK (b). Co-staining with a-integrin
a5 showed normal focal contacts of both cells with in-
duced FAK or DC14 expressions (Fig. 7, c and d).
We next analyzed tyrosine phosphorylation of the exog-
enous FAK and its association with intracellular signaling
molecules. Lysates were prepared from DC14, DC14F, and
WT FAK or Mock cells after induction of exogenous FAK
expression by removing tetracycline. They were immuno-
precipitated with a-HA, and the immune complexes were
Western blotted with a-FAK to verify similar expression
levels (Fig. 8 A) or with an anti-phosphotyrosine antibody,
PY20, to determine the in vivo phosphotyrosine levels of
the exogenous FAK (Fig. 8 B). As expected, the wild-type
FAK was phosphorylated on tyrosine residues in vivo (Fig.
8 B, lane 4). Surprisingly, DC14 was also highly phosphory-
lated in vivo (Fig. 8 B, lane 2) even though it was not tar-
geted to focal contacts (see Fig. 7). The double mutant
DC14F was not phosphorylated (Fig. 8 B, lane 3), suggest-
ing that DC14 was capable of autophosphorylation on resi-
due Y397. In vitro kinase assays of the a-HA immune
complexes indicated that DC14 (Fig. 8 B, lane 2) and
WT FAK (lane 4) had comparable autophosphorylation
activity (Fig. 8 C) and similar activity for the exogenous
substrate E4Y1 (D). Consistent with the in vivo phos-
phorylation data, the double mutant DC14F was not auto-
phosphorylated in in vitro kinase assays (Fig. 8 C, lane 3).
It also showed a reduced activity for E4Y1 (Fig. 8 D, lane
3), possibly resulting from the lack of association with Src
and Fyn (see below).
To detect FAK association with Src and Fyn, lysates
prepared from the induced cells were immunoprecipitated
with anti-Src (Fig. 8 E) or anti-Fyn (F) antibodies, and the
immune complexes were Western blotted with a-HA. As
expected, WT FAK was associated with Src and Fyn (Fig.
8, lane 4) while the DC14F mutant was not (lane 3). DC14
was associated with Src and Fyn to a similar extent as WT
FAK (compare lanes 2 and 4). These results showed that
the FAK mutant DC14 was not localized in focal contacts,
but was phosphorylated and associated with Src and Fyn.
Consistent with the requirement of Y397 for the dominant
negative effects, these results indicated that DC14 func-
tioned as a dominant negative mutant by competing with
the endogenous FAK in focal contacts for binding signal-
ing molecules like Src and/or Fyn.
Figure 6. Cell cycle distribution of cells expressing exogenous
FAK and mutants. (A) Quiescent (0 h) cells were stimulated with
10% CS in the presence (uninduced, U) or absence (induced, I)
of 0.4 mg/ml tetracycline for 16 h. The cells were then analyzed
for DNA content by staining with propidium iodide followed by
FACS¨, as described in Materials and Methods. (B) The decrease
in the proportion of cell in G1 at 16 h from that at 0 h was deter-
mined for cells expressing the indicated proteins under unin-
duced (open bars) and induced (closed bars) conditions. The re-
sults show mean 1 SE for at least three independent
experiments. *P 5 0.0011 and **P 5 0.013 in comparison to
value from uninduced cells.Zhao et al. Cell Cycle Regulation by FAK 2003
Inhibition of Src-family kinases has previously been
shown to cause cell cycle arrest (Twamley-Stein et al.,
1993; Roche et al., 1995). To determine if overexpression
of FAK or mutants affected the total activity of Src or Fyn
in these cells, the anti-Src or anti-Fyn immunocomplexes
were subjected to in vitro kinase assays using denatured
enolase as a substrate. Fig. 8 G showed that the total Src
kinase activities were similar in Mock, WT, DC14, and
DC14F cells. Similarly the total Fyn activities were compa-
rable in these cells (Fig. 8 H). These results further sup-
port our hypothesis that DC14 functioned as a dominant
negative mutant by reducing FAK-associated Src and/or
Fyn in focal contacts rather than by altering the total activ-
ities of Src or Fyn in these cells.
Role of Erk Activation in Cell Cycle Regulation by FAK
To further explore the mechanisms by which FAK mutant
DC14 inhibited cell cycle progression, we examined its ef-
fect on activation of Erk in integrin-mediated cell adhe-
sion. Mock or DC14 cells under either uninduced or in-
duced conditions were removed from the plates and either
maintained in suspension (Fig. 9, AÐC, lanes Sus) or re-
plated on fibronectin (FN; Fig. 9, AÐC, lanes FN). The
cells were then lysed and tested for FN adhesion-induced
Erk activity, as shown in Fig. 9. Consistent with previous
observations (Chen et al., 1994; Schlaepfer et al., 1994;
Zhu and Assoian, 1995), cell adhesion to FN caused Erk
activation in these cells (Fig. 9 B). However, induction of
DC14 expression significantly reduced the increase of Erk
activation in cell adhesion when compared with uninduced
cells or Mock cells under both induced and uninduced
conditions (Fig. 9, compare lane 7 with lanes 1, 3, and 5).
Western blotting with a-HA confirmed the induced ex-
pression of DC14 (Fig. 9 A). Blotting with anti-Erk anti-
body confirmed similar expression levels of Erks under all
conditions (Fig. 9 C). Quantitation of Erk activity from
three independent experiments indicated an z50% reduc-
tion in Erk activation by DC14 expression (Fig. 9 D).
Wary et al. (1996, 1998) have recently observed that
some integrins could activate Erk by coupling through
Shc, but not FAK. Since FAK has also been suggested to
mediate Shc activation by integrins (Schlaepfer et al.,
1998), it is possible that DC14 inhibited Erk by interfering
with Shc activation in cell adhesion. To examine this possi-
bility, lysates were prepared from suspended (Fig. 9, lanes
Sus) or FN-attached (lanes FN) Mock or DC14 cells under
either uninduced or induced conditions. They were immu-
noprecipitated with anti-Shc followed by Western blotting
with anti-PY to detect tyrosine-phosphorylated Shc, as de-
scribed previously (Wary et al., 1996, 1998). Surprisingly,
Fig. 9 E shows that no significant tyrosine phosphorylation
of Shc was detected under these conditions although ty-
rosine phosphorylation of Shc was detected in PDGF-
stimulated cells (Fig. 9 E, lane 9). Western blotting of the
immunoprecipitates with anti-Shc confirmed presence of
similar amount of Shc in all samples (Fig. 9 F). Taken to-
gether, these results demonstrated that Shc was not phos-
phorylated in cell adhesion to FN under our experimental
conditions, where Erk activation is observed (Fig. 9).
Therefore it is unlikely that DC14 inhibited Erk activation
by interfering with ShcÕs ability to couple integrins to Erk.
To further evaluate our hypothesis that DC14 func-
tioned as a dominant-negative mutant by reducing FAK-
associated Src and/or Fyn in focal contacts rather than by
interfering with Shc or other signaling pathways, we exam-
ined the effect of FAK COOH-terminal fragment FRNK
and its corresponding mutant lacking the last 14 amino
acids (FRNKDC14) on BrdU incorporation and Erk acti-
vation. Consistent with a previous report (Gilmore and
Figure 7. Subcellular local-
ization of DC14 and WT
FAK.  a-HA (a, b) and a-inte-
grin a5 (c, d) immunofluores-
cent staining of cells express-
ing DC14 (a, c) and WT (b, d).
Examples of focal contacts
are indicated by arrowheads.The Journal of Cell Biology, Volume 143, 1998 2004
Romer, 1996), we found that overexpression of FRNK re-
sulted in a decrease in BrdU incorporation in comparison
with the control HFF cells whereas FRNKDC14 had little
effect (Fig. 10 A). Because overexpression of FRNK (but
not FRNKDC14) can compete with FAK for focal contacts
localization (Gilmore and Romer, 1996; Richardson and
Parsons, 1996) and FRNK is not expected to bind Shc di-
rectly, these results further support our hypothesis that in-
teraction of FAK with signaling molecules such as Src and
Fyn in focal contacts is critical for cell cycle progression.
We then examined the effect of these constructs on Erk
activation in HFF cells. Cells were transiently transfected
with these FAK constructs along with a His-tagged Erk2.
As shown in Fig. 10 C, overexpression of FRNK signifi-
cantly reduced the increase of Erk activation in cell adhe-
sion when compared with mock-transfected cells (Fig. 10
C, compare lanes 3 and 1) whereas overexpression of
FRNKDC14 had little effect (lane 7). Overexpression of
Y397F also reduced Erk activation, although to a lesser
extent (lane 5). Western blotting with a-HA shows the ex-
pression levels of these FAK constructs (Fig. 10 B). Blot-
ting with anti-His antibody confirmed similar expression
levels of Erks under all conditions (Fig. 10 D). Quantita-
tion of Erk activity from four independent experiments in-
dicated an z50% and 35% reduction in Erk activation by
FRNK and Y397F, respectively (Fig. 10 E). The inhibition
of Erk activation by these FAK constructs correlated with
their effects on BrdU incorporation (see Figs. 1 and 10 A).
Taken together, these results suggested strongly that acti-
Figure 8. Biochemical analysis of FAK and mutants. Whole cell
lysates were prepared from cells that had been induced to express
the indicated proteins. They were immunoprecipitated by a-HA
(AÐD), a-Src (E, G) or a-Fyn (F, H) followed by Western blot
with a-FAK (A), PY20 (B), or a-HA (E, F), or in vitro kinase as-
say in the presence of E4Y1 (D) or enolase (G, H), or nothing
(C). The results show mean 1 SE of relative kinase activities
(normalized to expression levels in each experiment) normalized
to WT FAK from at least three independent experiments (D).
Figure 9. Effects of DC14 on Erk activation and Shc phosphory-
lation. Quiescent Mock or DC14 cells under uninduced (U) or in-
duced (I) conditions were detached by trypsin/EDTA (AÐD) or
EDTA alone (E, F) and either maintained in suspension (Sus) or
replated on fibronectin (FN), as described in Materials and Meth-
ods. Whole cell lysates were western blotted with a-HA (A) or
a-Erk (C), or immunoprecipitated by a-phospho-Erk followed
by in vitro kinase assay with MBP as substrate (B). (D) The aver-
age and standard deviation of relative Erk activites were ob-
tained from three independent experiments. The relative ac-
tivities were normalized to uninduced cells plated on FN.
Alternatively, the lysates were immunoprecipitated by a-Shc fol-
lowed by Western blotting with anti-PY (E) or anti-Shc (F). Ly-
sates from PDGF-stimulated cells were also used as a positive
control in E and F.Zhao et al. Cell Cycle Regulation by FAK 2005
vation of Erk in cell adhesion is mediated at least in part
by FAK and that inhibition of Erk activation by DC14 and
FRNK may play a role in inhibition of cell cycle progres-
sion.
Regulation of Cyclin D1 and p21 by FAK
Integrin-mediated cell adhesion has been found to regu-
late several cyclins and cyclin-dependent kinases (CDKs)
(Fang et al., 1996; Zhu et al., 1996; Assoian, 1997). There-
fore the effects of induced exogenous FAK expression on
these cell cycle regulators are examined. Fig. 11 A shows
that induction of DC14 expression increased p21 expres-
sion and reduced cyclin D1 expression (a and b, compare
lanes 4 and 3). Conversely, overexpression of WT FAK
decreased p21 expression and enhanced cyclin D1 expres-
sion (Fig. 11 A, a and b, compare lanes 8 and 7). The ex-
pression levels of p21 and cyclin D1 were not altered by in-
duction of DC14F expression (Fig. 11 A, a and b, compare
lanes 6 and 5). The expression levels of Cdk2, cyclin E, cy-
Figure 10. Effects of FAK constructs on BrdU incorporation and
Erk activation in HFF cells. (A) HFF cells were transiently trans-
fected with expression vectors encoding FRNK, FRNKDC14, or
pKH3 vector alone (Control). They were then analyzed for BrdU
incorporation as described in Materials and Methods. The per-
centage of BrdU (1)/positively transfected cells was determined
by analyzing 40Ð50 positively transfected cells for each transfec-
tion in multiple fields. The results show mean 1 SE for at least
three independent experiments. *P 5 0.001 in comparison to
value from control cells. (BÐE) HFF cells were transiently trans-
fected with expression vectors encoding FRNK, FRNKDC14,
Y397F (i.e., F397), or pKH3 vector alone (Mock). They were se-
rum starved, detached by trypsinization and then either main-
tained in suspension (Sus) or replated on fibronectin (FN), as de-
scribed in Materials and Methods. Whole cell lysates were
Western blotted with a-HA (B) or a-His (D), or immunoprecipi-
tated by a-His followed by in vitro kinase assay with MBP as sub-
strate (C). (E) The average and standard deviation of relative
Erk activites were obtained from four independent experiments.
The relative activities were normalized to MOCK cells plated on
FN. *P 5 0.015 and 0.052 in comparison to value from MOCK
cells on FN for cells transfected with FRNK and Y397F on FN,
respectively.
Figure 11. Regulation of the expression levels of components of
G1/S cyclin-Cdk complexes by exogenous FAK and mutants. (A)
a-p21,  a-cyclin D1, a-Cdk2,  a-cyclin E, a-cyclin A, or a-p27
Western blot of whole cell lysates prepared from cells expressing
the indicated proteins under uninduced (lanes U) and induced
(lanes I) conditions. (B) Serum-starved cells expressing DC14
were incubated in media containing 10% CS in the presence (U)
or absence (I) of tetracycline. At the indicated times, lysates were
prepared and analyzed by Western blot with a-p21, a-cyclin D1,
a-Cdk2, a-cyclin E, or a-cyclin A.The Journal of Cell Biology, Volume 143, 1998 2006
clin A, and p27 remained the same in all cells under either
induced or uninduced conditions (Fig. 11 A, cÐf).
Regulation of p21 and cyclin D1 by DC14 was then ex-
amined more closely by the following time course experi-
ments. Lysates were prepared from cells with or without
induced DC14 expression at various times after serum
stimulation. They were subjected to Western blot analysis
as shown in Fig. 11 B. Expression of DC14 was detected
4Ð8 h after induction and it reached a maximal level 12 h
after induction (data not shown and see Fig. 2). An in-
crease of p21 expression was observed in the induced cells
8Ð12 h after induction (Fig. 11 B, b) relative to that in un-
induced cells (Fig. 11 B, a). The reduction of cyclin D1 ex-
pression by DC14 was observed 12 h after tetracycline
removal (Fig. 11 B, c and d). Induction of DC14 expression
did not affect expression of Cdk2, cyclin E or cyclin A
(Fig. 11 B, eÐj). These results suggested that the altered ex-
pression of p21 and cyclin D1 was a consequence of DC14
expression and that DC14 inhibited cell cycle progression
by inducing p21 expression and/or decreasing cyclin D1
expression in G1 phase.
Discussion
In this paper, we examine the possible roles and mecha-
nisms of FAK in cell cycle regulation by integrins. We es-
tablished stable cell lines with tetracycline-regulated in-
ducible overexpression of exogenous FAK and mutants.
Using this inducible system as well as transient transfec-
tions, we showed that overexpression of WT FAK acceler-
ated G1 to S phase transition in both primary HFF cells
and NIH3T3 cells. Conversely, overexpression of a domi-
nant negative FAK mutant DC14 inhibited cell cycle pro-
gression at G1 phase and this inhibition required the Y397
in DC14. Biochemical analyses using the inducible expres-
sion system revealed that DC14 was mislocalized but still
associated with Src and Fyn. They also showed that DC14
reduced Erk activation in cell adhesion, blocked cyclin D1
upregulation, and induced p21 expression, whereas WT
FAK increased cyclin D1 expression and decreased p21
expression. Together these results demonstrate that FAK
serves as a mediator of cell cycle regulation by integrins.
They also suggest that FAK/Src complex formation in the
focal contacts, Erk activation, and cyclin D1 and/or p21
are some of the important FAK downstream events in the
signaling pathway leading to cell cycle regulation.
Results presented here are consistent with a previous
observation showing that inhibition of FAK by microinjec-
tion of the COOH-terminal fragment reduced BrdU in-
corporation in HUVEC and Balb/c 3T3 cells (Gilmore and
Romer, 1996). Interestingly, FAK2/2 cells have been de-
rived from FAK knockout mice, suggesting that FAK is
not required for cell proliferation under some conditions
(Ilic et al., 1995). However, these FAK2/2 cells do not
contain a functional p53 because a p53 mutation was intro-
duced into the embryo from which the FAK2/2 cells
were derived. Since it is a critical cell cycle regulator, the
lack of p53 might account for cell cycle progression with-
out FAK function in these cells. Alternatively, the proper-
ties of the FAK2/2 cells could be due to the increased ex-
pression of FAK-related kinases such as Pyk2, which may
serve to compensate some of the functions of FAK.
The use of an inducible expression system in stable cell
lines has allowed us to begin to investigate the mecha-
nisms of cell cycle regulation by FAK. Analyses of FAK
mutant DC14 showed that it was mislocalized but still ca-
pable of association with Src and Fyn. Furthermore, cell
cycle progression was not affected by the double mutant
DC14F that did not associate with Src family kinases as ex-
pected. These results suggested that DC14 functioned as a
dominant negative mutant by competing with endogenous
FAK in focal contacts for binding Src and/or Fyn. Consis-
tent with this, we also observed cell cycle inhibition by
Y397F mutant and FRNK, but not FRNKDC14, which are
expected to compete with endogenous FAK for focal con-
tacts localization. Src family kinases have been shown to
play a critical role in cell cycle regulation (Thomas and
Brugge, 1997). Inhibition of their activities blocked DNA
synthesis induced by several growth factors (Twamley-
Stein et al., 1993; Roche et al., 1995). However, our results
provide first evidence suggesting that the FAK complex
formation with Src family kinases in focal contacts (but
not necessarily the total Src family kinase activities, see
Fig. 8, G and H) is necessary for cell cycle regulation in
cell adhesion.
Recent studies have shown that integrin-mediated cell
adhesion can regulate several components of cell cycle
regulation machinery (Fang et al., 1996; Zhu et al., 1996;
Assoian, 1997; Day et al., 1997), although the intracellular
signaling pathways in cell cycle regulation by integrins are
largely unknown. Results in this report revealed that cy-
clin D1 and p21 are two major targets of FAK signaling
pathways in cell cycle regulation by integrins. Induced
overexpression of WT FAK increased cyclin D1 expres-
sion and decreased p21 expression whereas induction of
DC14 expression blocked cyclin D1 upregulation and in-
creased p21 expression. Wu and Schonthal (1997) recently
reported that disruption of cellÐmatrix interactions caused
rapid p21 upregulation via p53. It will be interesting to de-
termine whether regulation of p21 by FAK involves a sim-
ilar mechanism. If so, these results will further support the
notion that DC14 functions as a dominant-negative FAK
(inhibiting endogenous FAK function that results in p53
activation and then p21 upregulation). This will also be
consistent with the previous observation that loss of FAK
function did not cause cell cycle arrest in p53-deficient
cells (Ilic et al., 1995).
Integrin-mediated cell adhesion has been shown to reg-
ulate a number of cyclins including cyclin D1, cyclin E, and
cyclin A (Assoian, 1997). However, a recent report showed
that overexpression of cyclin D1 but not cyclin EÐinduced
anchorage-independent cell cycle progression, suggesting
that adhesion-dependent cell cycle regulation is mediated
through cyclin D1 (Resnitzky, 1997). Experiments are in
progress to determine whether cyclin D1 or p21 or both
are necessary for the effects of FAK and DC14 overex-
pression on cell cycle regulation. Nevertheless, these re-
sults are consistent with our conclusion that FAK is a me-
diator of cell cycle regulation by integrins.
Integrin-mediated cell adhesion has also been shown to
regulate expression levels of cyclin A (Assoian, 1997).
Furthermore, cyclin A expression is induced in a cyclin D/
Cdk4/6-dependent manner at G1/S transition. It is there-
fore surprising that we did not observe any change in cy-Zhao et al. Cell Cycle Regulation by FAK 2007
clin A expression in spite of the evident alterations in cy-
clin D expression upon induction of DC14 expression (Fig.
11). It is possible that the effects of FAK on cell cycle reg-
ulation may be more complex than its effect on cyclin D
expression. Future studies using the inducible expression
systems will be directed toward identifying additional fac-
tors involved in cell cycle regulation by FAK.
Two other intracellular signaling molecules Shc and ILK
have also been implicated in cell cycle regulation in cell
adhesion (Wary et al., 1996; Radeva et al., 1997). The sig-
naling pathways associated with ILK in cell cycle regu-
lation is unclear at present, although phosphorylation of
integrin cytoplasmic domain by ILK may be involved
(Hannigan et al., 1996). In contrast, Shc has also been
shown to link some integrins to the MAP kinase pathways.
Interestingly, we found that cell adhesion to FN induced
Erk activation in a FAK-dependent manner under the ex-
perimental conditions where Shc was not tyrosine phos-
phorylated (Fig. 9). Taken together these results suggest
that multiple pathways could be involved in cell cycle reg-
ulation by integrins. For example, overexpression of WT
FAK and DC14 affected expression levels of p21, but not
p27 (Fig. 11) whereas both p21 and p27 have been found
to be upregulated by disruption of cell adhesion (Assoian,
1997). This possibility may also explain the partial inhibi-
tion of new DNA synthesis by the DC14 mutant (Fig. 4).
Alternatively, the partial inhibition could be due to hetero-
geneity of expression in the clone. Co-staining with a-BrdU
and a-FAK indicated that the DC14 cells with BrdU incor-
poration contained less or almost undetectable level of the
exogenous DC14 (Fig. 4 B, a and b).
The mechanisms of regulation of cyclin D1 and/or p21
by FAK and its associated signaling molecules such as Src
and Fyn are not clear at present. Cell spreading has been
correlated with cell cycle progression at G1/S transition
(Chen et al., 1997). However, we did not detect any differ-
ences in cell spreading or adhesion to fibronectin among
the different cell lines upon induction of FAK or mutants
(data not shown). Apparently normal focal contacts were
also detected in cells expressing DC14, although we can
not exclude completely any subtle differences in these
structures among these cells (Fig. 8). In contrast we have
observed inhibition of Erk activity by DC14 (Fig. 9) and its
activation by inducible overexpression of WT FAK (data
not shown). These results are consistent with a previous
report showing Erk activation by transient transfection of
FAK into HEK293 cells (Schlaefper et al., 1997). How-
ever, FAK phosphorylation and Erk activation have been
dissociated under some other conditions (Lin et al., 1997).
Furthermore, Wary et al. (1996) have shown that some in-
tegrins activate Erk by coupling to Shc without affecting
FAK phosphorylation. It is not clear how to explain these
conflicting data at present, although it is possible that this
is due to the use of different cells and possibly subtle dif-
ferences in various approaches (e.g., stable expression vs
transient and inducible expression). In any case, the ef-
fects on the Erk activation by WT FAK and DC14 mutants
might account for the regulation of cyclin D1 expression
and cell cycle progression in our systems, as activation
of Erk has been shown to induce cyclin D1 expression
(Lavoie et al., 1996).
One surprising finding here is that the mislocalized FAK
mutant  DC14 was tyrosine phosphorylated in attached
cells (Fig. 8). Furthermore, tyrosine phosphorylation of
DC14 was regulated by cell adhesion in the same manner
as the WT FAK with more phosphorylation detected in at-
tached cells than in detached cells (data not shown). Al-
though the mechanism of FAK activation by integrins is
still unclear, it has been proposed that oligomerization of
FAK with integrins and other cytoskeletal proteins at the
focal contacts (i.e., focal contacts localization) is responsi-
ble for its activation (Giancotti, 1997; Guan, 1997). How-
ever, a FAK mutant lacking the focal adhesion targeting
sequence has been shown to be highly tyrosine phosphory-
lated in attached cells (Hildebrand et al., 1993), suggesting
that FAK activation and tyrosine phosphorylation may be
independent of its focal contacts localization. Consistent
with this, Lyman et al. (1997) have recently found that in-
tegrin-activated FAK phosphorylation was independent of
focal contacts formation in attached cells. These results
suggest the interesting possibility that FAK phosphoryla-
tion is regulated by proteins not present in focal contacts
such as the recently described protein tyrosine phospha-
tase PTEN (Li et al., 1997; Steck et al., 1997; Tamura et al.,
1998).
Although we have provided evidence suggesting the im-
portance of FAK/Src complex formation and Erk activa-
tion, other downstream effectors may also be involved in
cell cycle regulation by FAK. It has been shown that PI3
kinase binds to FAK also at Y397 (Chen et al., 1996) and
that Grb2 binding to FAK at Y925 depends on Y397 phos-
phorylation and Src binding (Schlaepfer et al., 1994). Fu-
ture studies with additional mutants that selectively dis-
rupt these interactions will be necessary to determine if
recruitment of these other signaling molecules to focal
contacts plays a role in cell cycle regulation by FAK.
Integrin signaling through FAK has been demonstrated
to regulate cell migration (Ilic et al., 1995; Cary et al., 1996;
Gilmore and Romer, 1996). Furthermore, phosphoryla-
tion of Y397 was necessary for FAK functions in both cell
migration and cell cycle regulation (Cary et al., 1996; this
study). Cell proliferation and migration are often coupled
under many physiological conditions such as wound heal-
ing and development. Thus FAK may play a role in the co-
ordinate regulation of these two cellular functions in re-
sponse to integrin-mediated cell adhesion.
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